Saskia Decuypere, Ph.D. - Publications

2007 Universiteit Antwerpen (Belgium) 

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Imamura H, Downing T, Van den Broeck F, Sanders MJ, Rijal S, Sundar S, Mannaert A, Vanaerschot M, Berg M, De Muylder G, Dumetz F, Cuypers B, Maes I, Domagalska M, Decuypere S, et al. Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent. Elife. 5. PMID 27003289 DOI: 10.7554/Elife.12613  0.6
2016 Decuypere S, Maltha J, Deborggraeve S, Rattray NJ, Issa G, Bérenger K, Lompo P, Tahita MC, Ruspasinghe T, McConville M, Goodacre R, Tinto H, Jacobs J, Carapetis JR. Towards Improving Point-of-Care Diagnosis of Non-malaria Febrile Illness: A Metabolomics Approach. Plos Neglected Tropical Diseases. 10: e0004480. PMID 26943791 DOI: 10.1371/journal.pntd.0004480  0.6
2016 Decuypere S, Meehan CJ, Van Puyvelde S, De Block T, Maltha J, Palpouguini L, Tahita M, Tinto H, Jacobs J, Deborggraeve S. Diagnosis of Bacterial Bloodstream Infections: A 16S Metagenomics Approach. Plos Neglected Tropical Diseases. 10: e0004470. PMID 26927306 DOI: 10.1371/journal.pntd.0004470  0.6
2014 Breitling R, Bakker BM, Barrett MP, Decuypere S, Dujardin JC. Metabolomic systems biology of protozoan parasites Genetics Meets Metabolomics: From Experiment to Systems Biology. 73-84. DOI: 10.1007/978-1-4614-1689-0_6  0.6
2013 Rijal S, Ostyn B, Uranw S, Rai K, Bhattarai NR, Dorlo TP, Beijnen JH, Vanaerschot M, Decuypere S, Dhakal SS, Das ML, Karki P, Singh R, Boelaert M, Dujardin JC. Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 56: 1530-8. PMID 23425958 DOI: 10.1093/Cid/Cit102  0.6
2013 Vanaerschot M, Decuypere S, Berg M, Roy S, Dujardin JC. Drug-resistant microorganisms with a higher fitness--can medicines boost pathogens? Critical Reviews in Microbiology. 39: 384-94. PMID 22950457 DOI: 10.3109/1040841X.2012.716818  0.6
2013 Dujardin JC, Decuypere S. Epidemiology of leishmaniasis in the time of drug resistance Drug Resistance in Leishmania Parasites: Consequences, Molecular Mechanisms and Possible Treatments. 65-84. DOI: 10.1007/978-3-7091-1125-3_4  0.6
2012 Vanaerschot M, Decuypere S, Downing T, Imamura H, Stark O, De Doncker S, Roy S, Ostyn B, Maes L, Khanal B, Boelaert M, Schönian G, Berriman M, Chappuis F, Dujardin JC, et al. Genetic markers for SSG resistance in Leishmania donovani and SSG treatment failure in visceral leishmaniasis patients of the Indian subcontinent. The Journal of Infectious Diseases. 206: 752-5. PMID 22753945 DOI: 10.1093/Infdis/Jis424  0.6
2012 Decuypere S, Vanaerschot M, Brunker K, Imamura H, Müller S, Khanal B, Rijal S, Dujardin JC, Coombs GH. Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background. Plos Neglected Tropical Diseases. 6: e1514. PMID 22389733 DOI: 10.1371/Journal.Pntd.0001514  0.6
2012 Downing T, Stark O, Vanaerschot M, Imamura H, Sanders M, Decuypere S, de Doncker S, Maes I, Rijal S, Sundar S, Dujardin JC, Berriman M, Schönian G. Genome-wide SNP and microsatellite variation illuminate population-level epidemiology in the Leishmania donovani species complex. Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases. 12: 149-59. PMID 22119748 DOI: 10.1016/J.Meegid.2011.11.005  0.6
2011 Downing T, Imamura H, Decuypere S, Clark TG, Coombs GH, Cotton JA, Hilley JD, de Doncker S, Maes I, Mottram JC, Quail MA, Rijal S, Sanders M, Schönian G, Stark O, et al. Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance. Genome Research. 21: 2143-56. PMID 22038251 DOI: 10.1101/Gr.123430.111  0.6
2011 Mukhopadhyay R, Mukherjee S, Mukherjee B, Naskar K, Mondal D, Decuypere S, Ostyn B, Prajapati VK, Sundar S, Dujardin JC, Roy S. Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells. International Journal For Parasitology. 41: 1311-21. PMID 21920365 DOI: 10.1016/J.Ijpara.2011.07.013  0.6
2011 Vanaerschot M, De Doncker S, Rijal S, Maes L, Dujardin JC, Decuypere S. Antimonial resistance in Leishmania donovani is associated with increased in vivo parasite burden. Plos One. 6: e23120. PMID 21829701 DOI: 10.1371/Journal.Pone.0023120  0.6
2011 Ouakad M, Vanaerschot M, Rijal S, Sundar S, Speybroeck N, Kestens L, Boel L, De Doncker S, Maes I, Decuypere S, Dujardin JC. Increased metacyclogenesis of antimony-resistant Leishmania donovani clinical lines. Parasitology. 138: 1392-9. PMID 21819638 DOI: 10.1017/S0031182011001120  0.6
2011 Adaui V, Castillo D, Zimic M, Gutierrez A, Decuypere S, Vanaerschot M, De Doncker S, Schnorbusch K, Maes I, Van der Auwera G, Maes L, Llanos-Cuentas A, Arevalo J, Dujardin JC. Comparative gene expression analysis throughout the life cycle of Leishmania braziliensis: diversity of expression profiles among clinical isolates. Plos Neglected Tropical Diseases. 5: e1021. PMID 21572980 DOI: 10.1371/Journal.Pntd.0001021  0.6
2011 Adaui V, Schnorbusch K, Zimic M, Gutiérrez A, Decuypere S, Vanaerschot M, DE Doncker S, Maes I, Llanos-Cuentas A, Chappuis F, Arévalo J, Dujardin JC. Comparison of gene expression patterns among Leishmania braziliensis clinical isolates showing a different in vitro susceptibility to pentavalent antimony. Parasitology. 138: 183-93. PMID 20678296 DOI: 10.1017/S0031182010001095  0.6
2010 t'Kindt R, Scheltema RA, Jankevics A, Brunker K, Rijal S, Dujardin JC, Breitling R, Watson DG, Coombs GH, Decuypere S. Metabolomics to unveil and understand phenotypic diversity between pathogen populations. Plos Neglected Tropical Diseases. 4: e904. PMID 21152055 DOI: 10.1371/Journal.Pntd.0000904  0.6
2010 t'Kindt R, Jankevics A, Scheltema RA, Zheng L, Watson DG, Dujardin JC, Breitling R, Coombs GH, Decuypere S. Towards an unbiased metabolic profiling of protozoan parasites: optimisation of a Leishmania sampling protocol for HILIC-orbitrap analysis. Analytical and Bioanalytical Chemistry. 398: 2059-69. PMID 20824428 DOI: 10.1007/s00216-010-4139-0  0.6
2010 Vanaerschot M, Maes I, Ouakad M, Adaui V, Maes L, De Doncker S, Rijal S, Chappuis F, Dujardin JC, Decuypere S. Linking in vitro and in vivo survival of clinical Leishmania donovani strains. Plos One. 5: e12211. PMID 20808916 DOI: 10.1371/Journal.Pone.0012211  0.6
2010 Zheng L, T'Kind R, Decuypere S, von Freyend SJ, Coombs GH, Watson DG. Profiling of lipids in Leishmania donovani using hydrophilic interaction chromatography in combination with Fourier transform mass spectrometry. Rapid Communications in Mass Spectrometry : Rcm. 24: 2074-82. PMID 20552712 DOI: 10.1002/rcm.4618  0.6
2010 Scheltema RA, Decuypere S, T'kindt R, Dujardin JC, Coombs GH, Breitling R. The potential of metabolomics for Leishmania research in the post-genomics era. Parasitology. 137: 1291-302. PMID 20109253 DOI: 10.1017/S0031182009992022  0.6
2009 Scheltema RA, Decuypere S, Dujardin JC, Watson DG, Jansen RC, Breitling R. Simple data-reduction method for high-resolution LC - MS data in metabolomics Bioanalysis. 1: 1551-1557. PMID 21083103 DOI: 10.4155/Bio.09.146  0.6
2009 Maurer-Cecchini A, Decuypere S, Chappuis F, Alexandrenne C, De Doncker S, Boelaert M, Dujardin JC, Loutan L, Dayer JM, Tulliano G, Arevalo J, Llanos-Cuentas A, Chizzolini C. Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials. Infection and Immunity. 77: 2022-9. PMID 19237520 DOI: 10.1128/Iai.01513-08  0.6
2008 Decuypere S, Vanaerschot M, Rijal S, Yardley V, Maes L, de Doncker S, Chappuis F, Dujardin JC. Gene expression profiling of Leishmania (Leishmania) donovani: overcoming technical variation and exploiting biological variation. Parasitology. 135: 183-94. PMID 17931458 DOI: 10.1017/S0031182007003782  0.6
2007 Rijal S, Yardley V, Chappuis F, Decuypere S, Khanal B, Singh R, Boelaert M, De Doncker S, Croft S, Dujardin JC. Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome? Microbes and Infection / Institut Pasteur. 9: 529-35. PMID 17350306 DOI: 10.1016/j.micinf.2007.01.009  0.6
2007 Laurent T, Rijal S, Yardley V, Croft S, De Doncker S, Decuypere S, Khanal B, Singh R, Schönian G, Kuhls K, Chappuis F, Dujardin JC. Epidemiological dynamics of antimonial resistance in Leishmania donovani: genotyping reveals a polyclonal population structure among naturally-resistant clinical isolates from Nepal. Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases. 7: 206-12. PMID 17010679 DOI: 10.1016/J.Meegid.2006.08.005  0.6
2006 Yardley V, Ortuno N, Llanos-Cuentas A, Chappuis F, Doncker SD, Ramirez L, Croft S, Arevalo J, Adaui V, Bermudez H, Decuypere S, Dujardin JC. American tegumentary leishmaniasis: Is antimonial treatment outcome related to parasite drug susceptibility? The Journal of Infectious Diseases. 194: 1168-75. PMID 16991093 DOI: 10.1086/507710  0.6
2005 Decuypere S, Rijal S, Yardley V, De Doncker S, Laurent T, Khanal B, Chappuis F, Dujardin JC. Gene expression analysis of the mechanism of natural Sb(V) resistance in Leishmania donovani isolates from Nepal. Antimicrobial Agents and Chemotherapy. 49: 4616-21. PMID 16251303 DOI: 10.1128/Aac.49.11.4616-4621.2005  0.6
2005 Decuypere S, Vandesompele J, Yardley V, De Donckeri S, Laurent T, Rijal S, Llanos-Cuentas A, Chappuis F, Arevalo J, Dujardin JC. Differential polyadenylation of ribosomal RNA during post-transcriptional processing in Leishmania. Parasitology. 131: 321-9. PMID 16178353 DOI: 10.1017/S0031182005007808  0.6
2005 Quispe-Tintaya KW, Laurent T, Decuypere S, Hide M, Bañuls AL, De Doncker S, Rijal S, Cañavate C, Campino L, Dujardin JC. Fluorogenic assay for molecular typing of the Leishmania donovani complex: taxonomic and clinical applications. The Journal of Infectious Diseases. 192: 685-92. PMID 16028139 DOI: 10.1086/432077  0.6
2005 De Doncker S, Hutse V, Abdellati S, Rijal S, Singh Karki BM, Decuypere S, Jacquet D, Le Ray D, Boelaert M, Koirala S, Dujardin JC. A new PCR-ELISA for diagnosis of visceral leishmaniasis in blood of HIV-negative subjects. Transactions of the Royal Society of Tropical Medicine and Hygiene. 99: 25-31. PMID 15550258 DOI: 10.1016/J.Trstmh.2004.01.015  0.6
2003 Decuypere S, Elinck E, Van Overmeir C, Talisuna AO, D'Alessandro U, Dujardin JC. Pathogen genotyping in polyclonal infections: application of a fluorogenic polymerase-chain-reaction assay in malaria. The Journal of Infectious Diseases. 188: 1245-9. PMID 14551896 DOI: 10.1086/378521  0.6
Show low-probability matches.